Higher mast cell load decreases the risk of Hymenoptera venom–induced anaphylaxis in patients with mastocytosis

References

Page 1

	Year	Citations
Second Symposium on the Definition and Management of Anaphylaxis: Summary Report—Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network Symposium Hugh A. Sampson, Anne Muñoz‐Furlong, Ronna L. Campbell, Annals of Emergency Medicine AsthmaDrug HypersensitivitySecond SymposiumAllergyAllergy Medicine	2006	743
Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho, Blood	2009	567
KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients Andrés C. García‐Montero Blood	2006	491
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: Importance of baseline serum tryptase—a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity Franziska Ruëff, Bernhard Przybilla, Maria Beatrice Bilò, Journal of Allergy and Clinical Immunology AllergyInsect Venom HypersensitivityAllergy MedicineEntomologyImmunology	2009	423
Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels Patrizia Bonadonna, Omar Perbellini, Giovanni Passalacqua, Journal of Allergy and Clinical Immunology Hymenoptera StingsAllergyMast Cell DisorderImmunologySystemic Reactions	2009	388
Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase† Franziska Ruëff, Bernhard Przybilla, Maria Beatrice Bilò, Journal of Allergy and Clinical Immunology AllergyClinical AllergyAllergy MedicineMedicineImmunology	2010	199
Over- and underestimated parameters in severe Hymenoptera venom–induced anaphylaxis: Cardiovascular medication and absence of urticaria/angioedema Johanna Stoevesandt, Johannes Hain, Andreas Kerstan, Journal of Allergy and Clinical Immunology AllergyMedicinePharmacologySevere HymenopteraCardiovascular Medication	2012	113
Inhibition of Type 1 Cytokine–mediated Inflammation by a Soluble CD30 Homologue Encoded by Ectromelia (Mousepox) Virus Margarida Saraiva, Philip Smith, Padraic G. Fallon, The Journal of Experimental Medicine	2002	88
Severe Life-Threatening or Disabling Anaphylaxis in Patients with Systemic Mastocytosis: A Single-Center Experience Friedrich Wimazal, Patrik Shnawa, Wolfgang R. Sperr, International Archives of Allergy and Immunology	2011	73
Basal serum tryptase as risk assessment for severe Hymenoptera sting reactions in elderly Emmanuella Guenova, Thomas Volz, Martin Eichner, Allergy	2010	69

Page 1